openPR Logo
Press release

Drug Eluting Stents Market Overall Study Report 2025-2032 | Abbott Laboratories, Boston Scientific Corporation, Medtronic

04-28-2025 12:03 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Drug Eluting Stents Market Overall Study Report 2025-2032 |

New Report Highlights Key Insights in the Drug Eluting Stents Market (2025-2032)

The Global Drug Eluting Stents Market is estimated to be valued at USD 8.49 Bn in 2025 and is expected to reach USD 15.22 Bn by 2032 exhibiting a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

Coherent Market Insights has published a detailed report titled "Drug Eluting Stents Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." This study offers a deep dive into the Drug Eluting Stents industry, covering market trends, growth drivers, challenges, competitive landscape, and regional insights. With 134 figures, tables, and charts, the report provides a data-rich analysis to help businesses understand the market's past, present, and future potential-enabling strategic planning and confident investment decisions.

Request Your Sample Copy of the US Tariff Impact Analysis Report @ https://www.coherentmarketinsights.com/insight/request-sample/566

Market Scope

This report provides a comprehensive segmentation of the Drug Eluting Stents market scope, covering product types, applications, end-user markets, key regions, and leading competitors. It offers expert insights into current market conditions, historical performance, production trends, and revenue forecasts.

The financial performance of key players is assessed, including gross profits, sales volumes, and manufacturing costs. Analytical tools like SWOT analysis and Porter's Five Forces are used to evaluate market dynamics. Additionally, the report includes a detailed review of major players, covering their financials, product benchmarking, and competitive strategies.

Major Industry Players: -

Abbott Laboratories, Boston Scientific Corporation, Medtronic, Terumo Corporation, B. Braun Melsungen AG, C. R. Bard Inc., Cook Medical Inc., Biotronik SE & Co. KG, MicroPort Scientific Corporation, St. Jude Medical (now part of Abbott), Johnson & Johnson, Cardiovascular Systems Inc., Gore Medical, InspireMD, Asahi Intecc Co., Ltd., and Z-Medica

The report provides a detailed analysis of the Drug Eluting Stents market key players. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

Market Segmentation:

This report offers an in-depth analysis of the political and economic factors influencing the Drug Eluting Stents market analysis, highlighting key risks and opportunities. It examines the competitive landscape, profiling leading players, their market share, strategies, and performance. Additionally, the study explores current market trends, technological developments, and emerging opportunities-providing actionable insights for businesses aiming to grow their market presence.

By Product Type: Polymer-based Coatings (Non-biodegradable Polymers, Biodegradable Polymers), Polymer free Coatings (Micro porous Surface, Micro structured Surface, Slotted Tubular Surface, and Nanoporous Surface
By Application: Coronary Artery Disease, Peripheral Artery Disease, and Others
By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers, and Others

Make Smarter Decisions - Buy the US Tariff Impact Analysis Report @ https://www.coherentmarketinsights.com/insight/buy-now/566

Geographical Landscape of the Drug Eluting Stents Market:

North America (United States, Canada, Mexico)
Europe (Germany, France, UK, Russia, Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia)
Latin America (Brazil, Argentina, Colombia)
Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)

Report Drivers & Trends Analysis:

The report also discusses the factors driving and restraining market growth, as well as their specific impact on demand over the forecast period. Also highlighted in this report are growth factors, developments, trends, challenges, limitations, and growth opportunities. This section highlights emerging Drug Eluting Stents Market trends and changing dynamics. Furthermore, the study provides a forward-looking perspective on various factors that are expected to boost the market's overall growth.

This report highlights essential aspects of leading market players, including:

✍ Business Description - An overview of company operations and departmental structure.
✍ Company Strategy - Analyst insights into each company's strategic direction.
✍ SWOT Analysis - In-depth evaluation of strengths, weaknesses, opportunities, and threats.
✍ Company History - A timeline of key milestones and developments.
✍ Main Products & Services - A breakdown of core offerings and brand portfolio.
✍ Main Competitors - Identification of primary industry rivals.
✍ Key Locations & Subsidiaries - A list of major offices, branches, and contact details.
✍ Financial Ratios (5-Year Overview) - Key performance indicators drawn from annual financial statements over the past five years.

Why You Should Buy This Report:

■The impact of technological advancements and emerging industry trends

■Regulatory and policy shifts and their implications for stakeholders

■Competitive landscape analysis, including key player profiles and growth strategies

■Major market challenges like supply chain issues and evolving consumer behavior

■Opportunities in new products, applications, and potential investment areas

Make Smarter Decisions - Buy the US Tariff Impact Analysis Report @ https://www.coherentmarketinsights.com/insight/buy-now/566

Key Questions Answered in the Report

✔ What are the projected market size, share, and CAGR for 2025-2032?
✔ Which key trends are expected to shape the market's future?
✔ What is the forecasted demand for various products and services?
✔ How will strategic developments influence the market mid to long term?
✔ Who are the major players and stakeholders in the market?
✔ What are the key market segments and sub-segments analyzed?

Author of this marketing PR:

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.

📌Contact Us:
Mr. Shah
Coherent Market Insights Pvt. Ltd,
📞U.S.: + 12524771362
📞U.K.: +442039578553
📞AUS: +61-2-4786-0457
📞INDIA: +91-848-285-0837
✉ Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Eluting Stents Market Overall Study Report 2025-2032 | Abbott Laboratories, Boston Scientific Corporation, Medtronic here

News-ID: 3990252 • Views:

More Releases from Coherent Market Insights

U.S. Hospital Beds Market Future Business Opportunities 2025-2032 | Invacare Corporation, Stryker Corporation, Paramount Bed Co. Ltd.
U.S. Hospital Beds Market Future Business Opportunities 2025-2032 | Invacare Cor …
New Report Highlights Key Insights in the U.S. Hospital Beds Market (2025-2032) The U.S hospital beds market is estimated to be valued at US$ 1,145.4 million in 2022 and expected to exhibit a CAGR of 5.8 % over the forecast period (2022-2030) Coherent Market Insights has published a detailed report titled "U.S. Hospital Beds Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." This study offers a deep dive into the
Hearing Aids Market Generated Opportunities, Future Scope 2025-2032 | Sonova, Starkey Laboratories Inc., GN Hearing
Hearing Aids Market Generated Opportunities, Future Scope 2025-2032 | Sonova, St …
New Report Highlights Key Insights in the Hearing Aids Market (2025-2032) Global hearing aids market is estimated to be valued at USD 8.64 Bn in 2025 and is expected to reach USD 13.52 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032. Coherent Market Insights has published a detailed report titled "Hearing Aids Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." This study
Enteral Feeding Devices Market Detailed In New Research Report 2025 | Abbott Laboratories, Cardinal Health, Inc., Boston Scientific Corporation
Enteral Feeding Devices Market Detailed In New Research Report 2025 | Abbott Lab …
New Report Highlights Key Insights in the Enteral Feeding Devices Market (2025-2032) Coherent Market Insights has published a detailed report titled "Enteral Feeding Devices Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." This study offers a deep dive into the Enteral Feeding Devices industry, covering market trends, growth drivers, challenges, competitive landscape, and regional insights. With 134 figures, tables, and charts, the report provides a data-rich analysis to help
Digital Pathology Market Future Business Opportunities 2025-2032 | Leica Biosystems Nussloch GmbH, Olympus Corporation, OracleBio Limited
Digital Pathology Market Future Business Opportunities 2025-2032 | Leica Biosyst …
New Report Highlights Key Insights in the Digital Pathology Market (2025-2032) Digital Pathology Market is estimated to be valued at USD 1,112.8 Mn in 2025 and is expected to reach USD 2,491.0 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 12.2% from 2025 to 2032. Coherent Market Insights has published a detailed report titled "Digital Pathology Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." This study

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug